Dino Mehic on BDUC: What Do We Know?
Dino Mehic, Physician Scientist at the Medical University of Vienna, shared on LinkedIn:
”Bleeding Disorder of Unknown Cause (BDUC): What Do We Know?
We are excited to share that we recently summarized nearly two decades of clinical and research experience in the management of patients with bleeding disorders of unknown cause (BDUC).
This review represents a long-standing, collaborative effort to better understand the natural history of BDUC led by Ingrid Pabinger, Johanna Gebhart, and Cihan Ay at our institution (Medical University of Vienna).
At the American Society of Hematology 2025 Annual Meeting in Orlando, Prof. Pabinger presented our current understanding of how to predict and treat BDUC-an important step toward improving care for this under-recognized patient population.”
Read the full article here.
Article: Predictors for future bleeding in bleeding disorder of unknown cause
Authors: Tim Dreier, Dino Mehic, Cihan Ay, Johanna Gebhart, Ingrid Pabinger
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 4, 2026, 18:57Connecting Haemophilia Centres, Certifying Treaters, and Improving National Data in Romania – EHC
-
Nov 4, 2026, 18:45Smitirupa Mishra: A Practical Guide to Coagulation Pathway Assessment and Laboratory Interpretation
-
Nov 4, 2026, 15:59Alessandra Bosch: A Successful Patient Day for the Bleeding Disorders Community in Zürich
-
Nov 4, 2026, 15:47Wolfgang Miesbach: Targeting Hepatic Endothelial Cells for Lentiviral Gene Therapy in Haemophilia A
-
Nov 4, 2026, 15:20Augustina Isioma Ikusemoro: Before You Transfuse, Think PBM
-
Nov 4, 2026, 14:23Advancing Hemophilia Care Through Global Research – WFH
-
Nov 4, 2026, 14:12Jean-Jacques Kiladjian: From JAK Inhibitor-Associated Skin Cancers to Laboratory Discovery
-
Nov 4, 2026, 13:59Rita Li: ASH 2026 Abstract Achievement Award for Gut Microbiome Research
-
Nov 4, 2026, 13:38Omid Seidizadeh: Improving Access to von Willebrand Disease Diagnosis and Treatment Across Europe